Krebs Biochemicals and Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krebs Biochemicals has informed the exchanges that the trading window for its securities will be closed from the end of business hours on 30th June 2025. The window will remain shut until 48 hours after the company declares its Unaudited Financial Results for Q1 (quarter ended 30th June 2025). This restriction applies to promoters, directors, designated persons, their immediate relatives, and all connected persons under the company's insider trading code. The board meeting date to consider these Q1 results will be communicated to the exchanges in due course. The filing is a standard regulatory compliance under SEBI's Prohibition of Insider Trading Regulations, 2015.
This is a routine compliance announcement and does not have a direct impact on shareholders or the stock price. It signals that Q1 FY26 results will be announced soon, which investors should watch for.